Accueil>>Signaling Pathways>> Others>>SOS1-IN-1

SOS1-IN-1

Catalog No.GC30511

SOS1-IN-1 est un inhibiteur sélectif et allostérique de SOS1. SOS1-IN-1 inhibe l'activation du site allostérique et partiellement inhibe l'activation du site catalytique. SOS1-IN-1 a un effet anticancéreux.

Products are for research use only. Not for human use. We do not sell to patients.

SOS1-IN-1 Chemical Structure

Cas No.: 4551-00-2

Taille Prix Stock Qté
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

SOS1-IN-1 is a SOS1 inhibitor.

The growth inhibitory rate (IR)=(average OD value in the control group-average OD value in the treatment group)/average OD value in the control group×100% are compared. Treatments with SOS1-IN-1 at 40 μM and NSC-658497 at 30 μM result in growth inhibitory rate of 29% and 8% respectively. The combination treatment results in growth inhibitory rate of 54%, showing the synergistic effect of SOS1-IN-1 and NSC-658497 on cell growth inhibition. It is showed that the treatment with NSC-658497 at 40 μM for 2 hours alone or in combìnation with the treatment with 40 μM of SOS1-IN-1 overnight resulted in lower expression levels of P-AKT and P-ERK. The treatment wlth 40 μM of SOS1-IN-1 overnight resulted in lower expression levels of P-ERK[1].

[1]. ARYL SULFONOHYDRAZIDES. WO 2016077793A1.

Avis

Review for SOS1-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SOS1-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.